Breast Cancer in Resource-Limited Countries

HER-2/neu Status: A Neglected Marker of Prognostication and Management of Breast Cancer Patients in India

“…Higher mortality rates of BC cases are usually common in developing countries like India than the developed countries, despite their comparatively lower prevalence rate. Diagnostic and detection methods followed for BC management in developed countries need to be replicated for BC patients of developing countries (Masood et al, 2010). Since, the last decade HER2/neu is considered as an important therapeutic target in standard breast cancer treatment across the globe.…”

Comparative cost‐effectiveness of fine needle aspiration biopsy versus image‐guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of affordable care act: A changing landscape

“…[16][17][18] The current inconsistency in the practice of breast health care, differences in opinions among those who are involved in the study and management of breast cancer patients and the absence of quality metrics constitute barriers in development of uniform guidelines that are costeffective, evidence based and patient friendly. Meanwhile, advancement in science and technology has resulted in increasing costs in delivery of patient care across the globe.…”

“…The reasons for this discrepancy are numerous, but barriers often evolve around poor socioeconomic status and limited breast health education and awareness. [16][17][18] The current inconsistency in the practice of breast health care, differences in opinions among those who are involved in the study and management of breast cancer patients and the absence of quality metrics constitute barriers in development of uniform guidelines that are costeffective, evidence based and patient friendly. Contributing factors for the current inappropriate utilization of resources include financially driven health care practices, increased patient demand for more testing and medicalegal considerations.…”

Moving toward Appropriateness of Breast Cancer Care: A Balanced Act to Redefine the Scope of Standard of Care

“…These efforts have made a difference in the betterment of quality of life of many breast cancer patients in resource rich countries. However, low-income countries and medically underserved populations across the globe still suffer from the serious gaps that continue to exist in every step during the course of diagnosis and follow-up management of breast cancer patients [2].…”